» Articles » PMID: 20597076

Improved Gas Exchange and Survival After KL-4 Surfactant in Newborn Pigs with Severe Acute Lung Injury

Overview
Date 2010 Jul 3
PMID 20597076
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To determine the effectiveness of artificial surfactant therapy using KL-4 surfactant in newborn pigs with hydrochloric acid (HCl)-induced acute lung injury (ALI).

Design: After induction of ALI via intratracheal HCl instillation, pigs were randomized to receive 5.8 ml/kg KL-4 surfactant or no surfactant prior to extubation to bubble CPAP.

Setting: Clinical laboratory.

Subjects: Spontaneously breathing newborn pigs (<1 week of age).

Interventions: Treatment with KL-4 surfactant on bubble CPAP with PEEP of 6 cmH(2)O for 3.5 hr after extubation compared with controls.

Measurements: Physiologic parameters and arterial blood gases were measured every 15 min. At the conclusion of the study, the lungs were excised for the analysis of histopathology and morphometric data.

Main Results: Pigs treated with KL-4 surfactant had arterial blood gases with less acidosis (P < 0.001), higher P(a)O(2) levels (P < 0.001), and lower P(a)CO(2) levels (P < 0.001). Pigs treated with KL-4 surfactant had improved survival compared with controls (6/12 KL-4, 2/12 control, P < 0.05). Postmortem morphometric data demonstrated that pigs treated with KL-4 surfactant had larger (P < 0.05) exchange units in the caudal-dorsal lung as compared to relatively atelectatic region in the control animals.

Conclusions: In newborn pigs with severe HCl-induced ALI, treatment with KL-4 surfactant resulted in improved respiratory parameters, less dependent atelectasis, and improved short-term survival.

Citing Articles

Structural and haemodynamic evaluation of less invasive surfactant administration during nasal intermittent positive pressure ventilation in surfactant-deficient newborn piglets.

Mielgo V, Gastiasoro E, Salomone F, Ricci F, Gomez-Solaetxe M, Olazar L PLoS One. 2023; 18(4):e0284750.

PMID: 37115799 PMC: 10146512. DOI: 10.1371/journal.pone.0284750.


Efficacy of surfactant therapy of ARDS induced by hydrochloric acid aspiration followed by ventilator-induced lung injury - an animal study.

Mikolka P, Kosutova P, Kolomaznik M, Mateffy S, Nemcova N, Mokra D Physiol Res. 2023; 71(S2):S237-S249.

PMID: 36647912 PMC: 9906666. DOI: 10.33549/physiolres.935003.


Surfactant nebulization therapy during NIPPV ventilation in surfactant-deficient newborn piglets.

Rey-Santano C, Mielgo V, Gastiasoro E, Bianco F, Salomone F, Gomez-Solaetxe M Pediatr Pulmonol. 2021; 56(7):2125-2135.

PMID: 33960742 PMC: 8252521. DOI: 10.1002/ppul.25425.


Aerosol drug delivery to spontaneously-breathing preterm neonates: lessons learned.

Bianco F, Salomone F, Milesi I, Murgia X, Bonelli S, Pasini E Respir Res. 2021; 22(1):71.

PMID: 33637075 PMC: 7908012. DOI: 10.1186/s12931-020-01585-9.


Nebulized Poractant Alfa Reduces the Risk of Respiratory Failure at 72 Hours in Spontaneously Breathing Surfactant-Deficient Newborn Piglets.

Rey-Santano C, Mielgo V, Gomez-Solaetxe M, Bianco F, Salomone F, Loureiro B Crit Care Med. 2020; 48(6):e523-e531.

PMID: 32301841 PMC: 7237025. DOI: 10.1097/CCM.0000000000004318.